← Leaderboards
Gregory M Lucas
Johns Hopkins University
$25,457,285
Attributed
$39,382,648
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,382,648 · 12
By mechanism
R01$36,463,302 · 7
K24$1,515,579 · 1
K23$784,275 · 1
M01$619,492 · 3
Top collaborators
- Shruti H Mehta16 shared
- Kathleen R Page7 shared
- Oluwaseun Falade-Nwulia3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Richard E Chaisson$50,014,616
- Stephen John Gange$36,428,543
- Gloria M. Petersen$29,119,396
- Anirban Maitra$50,247,714
- David D. Celentano$57,488,358
Others in their field
Top investigators on “Caring”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$279,179,778
- Chanza Baytop · Westat, Inc.$271,217,917
- Larry Arthur$256,720,406
Research focus
CaringPersonsParticipantMedicalInjecting Drug UserHiv InfectionsAntiretroviral TherapyViralClinicCommunitiesEpidemicLinkCohortSamplingTreatment OutcomeResponseServicesEffectivenessBasePharmaceutical PreparationsEvaluationHuman Immunodeficiency Virus TestInnovationAids Prevention
Grant awards (60)
Implementation of telemedicine and social network driven HIV service uptake for comprehensive HIV service integration in rural syringe service programs$1,155,553
R01 · FY2025 · DA
PWID Opportunities to Improve TrEat and Retain (POINTER)$465,879
R01 · FY2025 · DA · contact PI
PWID Opportunities to Improve TrEat and Retain (POINTER)$401,856
R01 · FY2025 · DA · contact PI
Implementation of telemedicine and social network driven HIV service uptake for comprehensive HIV service integration in rural syringe service programs$1,158,132
R01 · FY2024 · DA
PWID Opportunities to Improve TrEat and Retain (POINTER)$991,640
R01 · FY2024 · DA · contact PI
Treatment outcomes and comorbidity in HIV-infected IDU$136,042
K24 · FY2024 · DA · contact PI
PWID Opportunities to Improve TrEat and Retain (POINTER)$1,060,610
R01 · FY2023 · DA · contact PI
Implementation of telemedicine and social network driven HIV service uptake for comprehensive HIV service integration in rural syringe service programs$920,447
R01 · FY2023 · DA
Treatment outcomes and comorbidity in HIV-infected IDU$136,042
K24 · FY2023 · DA · contact PI
PWID Opportunities to Improve TrEat and Retain (POINTER)$1,043,280
R01 · FY2022 · DA · contact PI
Building on Needle Exchange to Optimize HIV Prevention/Treatment$509,046
R01 · FY2022 · DA · contact PI
Treatment outcomes and comorbidity in HIV-infected IDU$136,042
K24 · FY2022 · DA · contact PI
Strategies to improve the HIV care continuum among key populations in India$1,264,017
R01 · FY2021 · DA · contact PI
Building on Needle Exchange to Optimize HIV Prevention/Treatment$997,878
R01 · FY2021 · DA · contact PI
Treatment outcomes and comorbidity in HIV-infected IDU$136,042
K24 · FY2021 · DA · contact PI
Juntos (Together): A community led approach to enhance to Covid-19 testing among vulnerable Latinos$1,570,444
R01 · FY2020 · DA · contact PI
Strategies to improve the HIV care continuum among key populations in India$1,413,255
R01 · FY2020 · DA · contact PI
Building on Needle Exchange to Optimize HIV Prevention/Treatment$998,636
R01 · FY2020 · DA · contact PI
PWID Opportunities to Improve TrEat and Retain (POINTER)$864,464
R01 · FY2020 · DA · contact PI
Early-Stage Chronic Kidney Disease in HIV-infected Individuals$603,393
R01 · FY2020 · DA · contact PI
Treatment outcomes and comorbidity in HIV-infected IDU$136,042
K24 · FY2020 · DA · contact PI
Building on Needle Exchange to Optimize HIV Prevention/Treatment$886,061
R01 · FY2019 · DA · contact PI
Early-Stage Chronic Kidney Disease in HIV-infected Individuals$625,114
R01 · FY2019 · DA · contact PI
Strategies to improve the HIV care continuum among key populations in India$1,422,171
R01 · FY2018 · DA · contact PI
Building on Needle Exchange to Optimize HIV Prevention/Treatment$880,508
R01 · FY2018 · DA · contact PI
Treatment outcomes and comorbidity in HIV-infected IDU$164,685
K24 · FY2018 · DA · contact PI
Strategies to improve the HIV care continuum among key populations in India$1,424,389
R01 · FY2017 · DA · contact PI
Building on Needle Exchange to Optimize HIV Prevention/Treatment$955,194
R01 · FY2017 · DA · contact PI
Early-Stage Chronic Kidney Disease in HIV-infected Individuals$620,459
R01 · FY2017 · DA · contact PI
Treatment outcomes and comorbidity in HIV-infected IDU$165,901
K24 · FY2017 · DA · contact PI
Early-Stage Chronic Kidney Disease in HIV-infected Individuals$618,943
R01 · FY2016 · DA · contact PI
Treatment outcomes and comorbidity in HIV-infected IDU$167,171
K24 · FY2016 · DA · contact PI
Strategies to improve the HIV care continuum among key populations in India$1,169,991
R01 · FY2015 · DA · contact PI
Integrated Care Clinics for IDUs in India: a cluster randomized trial$1,068,055
R01 · FY2015 · DA · contact PI
Early-Stage Chronic Kidney Disease in HIV-infected Individuals$692,038
R01 · FY2015 · DA · contact PI
Treatment outcomes and comorbidity in HIV-infected IDU$168,171
K24 · FY2015 · DA · contact PI
Integrated Care Clinics for IDUs in India: a cluster randomized trial$1,537,931
R01 · FY2014 · DA · contact PI
Early-Stage Chronic Kidney Disease in HIV-infected Individuals$481,934
R01 · FY2014 · DA · contact PI
Treatment outcomes and comorbidity in HIV-infected IDU$169,441
K24 · FY2014 · DA · contact PI
Integrated Care Clinics for IDUs in India: a cluster randomized trial$1,302,274
R01 · FY2013 · DA · contact PI
Early-Stage Chronic Kidney Disease in HIV-infected Individuals$485,171
R01 · FY2013 · DA · contact PI
Integrated Care Clinics for IDUs in India: a cluster randomized trial$1,279,936
R01 · FY2012 · DA · contact PI
Early-Stage Chronic Kidney Disease in HIV-infected Individuals$516,855
R01 · FY2012 · DA · contact PI
Integrated Care Clinics for IDUs in India: a cluster randomized trial$1,109,080
R01 · FY2011 · DA · contact PI
Early-Stage Chronic Kidney Disease in HIV-infected Individuals$532,944
R01 · FY2011 · DA · contact PI
Early-Stage Chronic Kidney Disease in HIV-infected Individuals$545,318
R01 · FY2010 · DA · contact PI
Directly Administered HIV Therapy in Methadone Clinics$517,368
R01 · FY2009 · DA · contact PI
DIRECTLY ADMINISTERED HIV THERAPY IN METHADONE CLINICS$608,055
R01 · FY2008 · DA · contact PI
Directly Administered HIV Therapy in Methadone Clinics$515,023
R01 · FY2007 · DA · contact PI
BEEHIVE$420,694
M01 · FY2007 · RR · contact PI
Directly Administererd HIV Therapy In Methadone Clinics$114,351
R01 · FY2007 · DA · contact PI
DIRECTLY ADMINISTERERD HIV THERAPY IN METHADONE CLINICS$538,341
R01 · FY2006 · DA · contact PI
BUPRENORPHINE STUDY$195,107
M01 · FY2006 · RR · contact PI
Directly observed antiretroviral therapy in drug abusers$165,151
K23 · FY2006 · DA · contact PI
BEEHIVE$3,691
M01 · FY2006 · RR · contact PI
DIRECTLY ADMINISTERERD HIV THERAPY IN METHADONE CLINICS$597,268
R01 · FY2005 · DA
Directly observed antiretroviral therapy in drug abusers$160,456
K23 · FY2005 · DA
Directly observed antiretroviral therapy in drug abusers$155,869
K23 · FY2004 · DA
Directly observed antiretroviral therapy in drug abusers$151,442
K23 · FY2003 · DA
Directly observed antiretroviral therapy in drug abusers$151,357
K23 · FY2002 · DA